NHP Pharmacology

Over 50% failure of new drug development is due to the lack of enough therapeutic efficacies in clinical trails. It is especially true for the novel compounds of large molecules and biologics when they are human-specifically targeted, however, advanced based the research data of small animals. To improve the success assurance of new drug development, Prisys brings its innovative NHP pharmacology models and relevant technologies to global pharmaceutical industries for more meaningful studies in direct relevance to the clinical applications.


Prisys’ monkey models cover a broad range of disease areas, including immunology, inflammation, hematology, nephrology, hepatology, pulmonology, and gynecology, etc. While in the continuous expansion of NHP models, Prisys also co-develops customized models with sponsor’s collaboration.